Interestingly, these immune factors, including CD3+, CD4+, and IgG, were significantly different between MSA patients and healthy controls but did not change between different disease stages, suggesting that these factors could be useful indicators for diagnosis of MSA during the entire disease progression. Here, CD4 is linked to multiple system atrophy.